Fresenius Kabi Deutschland Gmbh

K+s Aktiengesellschaft

K+s Minerals and Agriculture Gmbh

Martin Westphal

Silke Baasner

Edmundo Brito De La Fuente

Crispulo Gallegos-Montes

Stefanie Honndorf

Lida Quinchia

Edmundo Brito-De-La-Fuente

Christoph Palm

Ines Feldberg

Matthias Kockx

Michael Lesch

Hans-Joachim Kind

Albrecht Palm

The present invention relates to the enhancement of the efficacy of anticancer agents by a composition comprising an aqueous phase, an oil phase, EPA and DHA for use in the treatment of solid tumors, wherein EPA and DHA are present in an amount of at least 65% based on the total weight of the oil phase wherein the composition comprises EPA and DHA in a weight ratio between 1:2 and 1:4, or wherein the composition comprises EPA and DHA in a weight ratio between 6:1 and 4:1 and wherein the treatment comprises administering the composition and administering at least one anticancer agent.

Composition comprising EPA and DHA for an enhanced efficacy of anticancer agents

The present invention relates to hydroxyalkyl starch or a pharmaceutical preparation thereof for the treatment of a hematological neoplasm, especially by effectively reducing proliferation rate of cancer cells and inhibiting cancer cell growth and wherein the hydroxyalkyl starch has a mean molecular weight (MW) above 20 and below 1300 kDa and a molar substitution (MS) in the range of from 0.1 to 1.5, wherein the alkylation may be an ethylation, propylation or butylation or mixes thereof; and wherein the alkyl may be further substituted.

Hydroxyalkyl starch for the treatment of hematological neoplasms

Growing community of inventors

Bad Homburg, Germany

Martin Westphal